Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg

NCT00350207 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

388

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Tiotropium bromide
DRUG: Placebo
DRUG: Salmeterol xinafoate

Sponsor

Boehringer Ingelheim